1Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladdercancer: past, present and an uncertain future. Surg Oncol 2012; 21:e183-e191 [PMID: 23025910 DOI: 10.1016/j.suronc.2012.08.002].
2Raki- M, Patrlj L, Kopljar M, Kli-ek R, Kolovrat M, Loncar B,Busic Z. Gallbladder cancer. Hepatobiliary Surg Nutr 2014; 3:221-226 [PMID: 25392833 DOI: 10.3978/j.issn.2304-3881.2014.09.03].
3Manfredi S, Benhamiche AM, Isambert N, Prost P, Jouve JL,Faivre J. Trends in incidence and management of gallbladdercarcinoma: a population-based study in France. Cancer 2000; 89:757-762 [PMID: 10951337].
4Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L,Tang J, Chen J, Wei K, Huang S, Wang J, Yu L, Zhao D, SongG, Chen J, Shen Y, Yang X, Gu X, Jin F, Li Q, Li Y, Ge H, ZhuF, Dong J, Guo G, Wu M, Du L, Sun X, He Y, Coleman MP,Baade P, Chen W, Yu XQ. Cancer survival in China, 2003-2005: apopulation-based study. Int J Cancer 2015; 136: 1921-1930 [PMID:25242378 DOI: 10.1002/ijc.29227].
5Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H,Ohta T. Prognostic factors for gallbladder cancer in Japan. AnnSurg 2008; 248: 807-814 [PMID: 18948808 DOI: 10.1097/SLA.0b013e31818a1561].
6Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, BaoRF, Shu YJ, Ding QC, Mu JS, Gu J, Dong P, Liu YB. Evaluationof two inflammation-based prognostic scores in patients withresectable gallbladder carcinoma. Ann Surg Oncol 2014; 21:449-457 [PMID: 24081806 DOI: 10.1245/s10434-013-3292-z].
7Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ,Peng ZH. Combined detection tumor markers for diagnosis andprognosis of gallbladder cancer. World J Gastroenterol 2014; 20:4085-4092 [PMID: 24744600 DOI: 10.3748/wjg.v20.i14.4085].
9Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-relatedinflammation. Nature 2008; 454: 436-444 [PMID: 18650914 DOI:10.1038/nature07205].
10Mantovani A, Romero P, Palucka AK, Marincola FM.Tumour immunity: effector response to tumour and role of themicroenvironment. Lancet 2008; 371: 771-783 [PMID: 18275997DOI: 10.1016/S0140-6736].
